In Canada, the brand name for a prescription drug must be selected bearing in mind not only trademark registrationissues pursuant to the Trademarks Act and within the domain of the Canadian Trademarks Office, but also regulatorymatters handled by the Therapeutic Products Directorate of Health Canada. While both deal with brand name approvaland issues of confusion, their underlying focus is quite different.


Get unlimited access to all WTR content